The familial Parkinsonism gene LRRK2 regulates neurite process morphology - PubMed (original) (raw)
The familial Parkinsonism gene LRRK2 regulates neurite process morphology
David MacLeod et al. Neuron. 2006.
Free article
Abstract
Mutations in LRRK2 underlie an autosomal-dominant, inherited form of Parkinson's disease (PD) that mimics the clinical features of the common "sporadic" form of PD. The LRRK2 protein includes putative GTPase, protein kinase, WD40 repeat, and leucine-rich repeat (LRR) domains of unknown function. Here we show that PD-associated LRRK2 mutations display disinhibited kinase activity and induce a progressive reduction in neurite length and branching both in primary neuronal cultures and in the intact rodent CNS. In contrast, LRRK2 deficiency leads to increased neurite length and branching. Neurons that express PD-associated LRRK2 mutations additionally harbor prominent phospho-tau-positive inclusions with lysosomal characteristics and ultimately undergo apoptosis.
Similar articles
- LRRK2 and neurodegeneration.
Santpere G, Ferrer I. Santpere G, et al. Acta Neuropathol. 2009 Mar;117(3):227-46. doi: 10.1007/s00401-008-0478-8. Epub 2009 Jan 14. Acta Neuropathol. 2009. PMID: 19142648 Review. - The biology and pathobiology of LRRK2: implications for Parkinson's disease.
Moore DJ. Moore DJ. Parkinsonism Relat Disord. 2008;14 Suppl 2:S92-8. doi: 10.1016/j.parkreldis.2008.04.010. Epub 2008 Jul 7. Parkinsonism Relat Disord. 2008. PMID: 18602856 Review. - Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression.
Henry AG, Aghamohammadzadeh S, Samaroo H, Chen Y, Mou K, Needle E, Hirst WD. Henry AG, et al. Hum Mol Genet. 2015 Nov 1;24(21):6013-28. doi: 10.1093/hmg/ddv314. Epub 2015 Aug 6. Hum Mol Genet. 2015. PMID: 26251043 - Lovastatin protects neurite degeneration in LRRK2-G2019S parkinsonism through activating the Akt/Nrf pathway and inhibiting GSK3β activity.
Lin CH, Lin HI, Chen ML, Lai TT, Cao LP, Farrer MJ, Wu RM, Chien CT. Lin CH, et al. Hum Mol Genet. 2016 May 15;25(10):1965-1978. doi: 10.1093/hmg/ddw068. Epub 2016 Feb 29. Hum Mol Genet. 2016. PMID: 26931464 - Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein.
Lin X, Parisiadou L, Gu XL, Wang L, Shim H, Sun L, Xie C, Long CX, Yang WJ, Ding J, Chen ZZ, Gallant PE, Tao-Cheng JH, Rudow G, Troncoso JC, Liu Z, Li Z, Cai H. Lin X, et al. Neuron. 2009 Dec 24;64(6):807-27. doi: 10.1016/j.neuron.2009.11.006. Neuron. 2009. PMID: 20064389 Free PMC article.
Cited by
- Micro-and mesoscale aspects of neurodegeneration in engineered human neural networks carrying the LRRK2 G2019S mutation.
Valderhaug VD, Ramstad OH, van de Wijdeven R, Heiney K, Nichele S, Sandvig A, Sandvig I. Valderhaug VD, et al. Front Cell Neurosci. 2024 Apr 5;18:1366098. doi: 10.3389/fncel.2024.1366098. eCollection 2024. Front Cell Neurosci. 2024. PMID: 38644975 Free PMC article. - Formation of templated inclusions in a forebrain α-synuclein mouse model is independent of LRRK2.
Dues DJ, Ma Y, Nguyen APT, Offerman AV, Beddows I, Moore DJ. Dues DJ, et al. Neurobiol Dis. 2023 Nov;188:106338. doi: 10.1016/j.nbd.2023.106338. Epub 2023 Oct 29. Neurobiol Dis. 2023. PMID: 38435455 Free PMC article. - LRRK2; Communicative Role in the Treatment of Parkinson's Disease and Ulcerative Colitis Overlapping.
Lashgari NA, Roudsari NM, Niknejad A, Shamsnia HS, Shayan M, Shalmani LM, Momtaz S, Rezaei N, Abdolghaffari AH. Lashgari NA, et al. CNS Neurol Disord Drug Targets. 2024;23(10):1177-1188. doi: 10.2174/0118715273270874231205050727. CNS Neurol Disord Drug Targets. 2024. PMID: 38279762 Review. - A Glance at Biogenesis and Functionality of MicroRNAs and Their Role in the Neuropathogenesis of Parkinson's Disease.
Szelągowski A, Kozakiewicz M. Szelągowski A, et al. Oxid Med Cell Longev. 2023 Jun 8;2023:7759053. doi: 10.1155/2023/7759053. eCollection 2023. Oxid Med Cell Longev. 2023. PMID: 37333462 Free PMC article. Review. - The Relationship between Iron and LRRK2 in a 6-OHDA-Induced Parkinson's Disease Model.
Jia R, Liu Y, Shuai K, Zhou C, Chen L, Zhu L, Wu XM. Jia R, et al. Int J Mol Sci. 2023 Feb 13;24(4):3709. doi: 10.3390/ijms24043709. Int J Mol Sci. 2023. PMID: 36835121 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases